Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Calidi Biotherapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
TuHURA Biosciences Inc. August 18, 202692.3%
-
Processa Pharmaceuticals Inc. July 30, 2026100.0%
-
Processa Pharmaceuticals Inc. July 18, 2025100.0%
-
TuHURA Biosciences Inc. June 23, 202591.0%
-
Processa Pharmaceuticals Inc. June 28, 2024100.0%
-
Calidi Biotherapeutics Inc. August 28, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 8, 2026 | Processa Pharmaceuticals Inc. | Option exercise | +1,600 | — | — |
| Jul 1, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +3,057 | $1.93 | $5,900 |
| Jun 15, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +2,465 | $2.22 | $5,472 |
| May 29, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +2,129 | $2.57 | $5,472 |
| May 15, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,843 | $2.97 | $5,474 |
| Apr 30, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +2,034 | $2.69 | $5,471 |
| Apr 15, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +1,843 | $2.97 | $5,474 |
| Mar 31, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +2,136 | $2.54 | $5,425 |
| Jan 27, 2025 | Processa Pharmaceuticals Inc. | Open-market purchase | +87,200 | $0.80 | $69,760 |
| Jan 30, 2024 | Processa Pharmaceuticals Inc. | Open-market purchase | +10,000 | $2.70 | $27,000 |
| Oct 12, 2023 | Processa Pharmaceuticals Inc. | Grant or award | +100,000 | $0.25 | $25,000 |
| Oct 10, 2023 | Processa Pharmaceuticals Inc. | Grant or award | +100,000 | $0.25 | $25,000 |
Questions about George K. Ng
What boards is George K. Ng on?
George K. Ng sits on the boards of Calidi Biotherapeutics Inc., Processa Pharmaceuticals Inc. and TuHURA Biosciences Inc.
What company is George K. Ng the CEO of?
George K. Ng is Chief Executive Officer of Processa Pharmaceuticals Inc.
How long has George K. Ng served on boards?
Our records show at least 8 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.